[ Price : $8.95]
FDA approves Baxters Feiba indicated for preventing or reducing the frequency of bleeding episodes in patients with hemophilia A o...[ Price : $8.95]
Amgen reports that its Phase 3 DESCARTES study of evolocumab in patients with high cholesterol met its primary endpoint of percent...[ Price : $8.95]
Wharton School of Business professors say that recent regulatory action against the personal genetic tests marketed by 23andMe spe...[ Price : $8.95]
PhRMAs general counsel says FDA and industry need to revisit how the biopharmaceutical industry communicates with healthcare profe...[ Price : $8.95]
Federal Register Notice: FDA and the Centers for Medicare and Medicaid Services will extend a pilot program for an additional two ...[ Price : $8.95]
FDA grants orphan drug designation to Versartis for its long-acting form of recombinant human growth hormone.[ Price : $8.95]
Mylan signs an agreement with Pfizer for worldwide rights to develop a novel long-acting muscarinic antagonist compound for variou...[ Price : $8.95]
Scientists from two U.S. government national laboratories recommend using certain X-rays to speed investigations aimed at understa...